Status:
UNKNOWN
Quality of Life After COVID-19 Related Acute respIratory Distress Syndrome Among ICU Survivors Patients in Italy: the ODISSEA Study.
Lead Sponsor:
Azienda Sanitaria-Universitaria Integrata di Udine
Conditions:
Covid19
Post Traumatic Stress Disorder
Eligibility:
All Genders
18-99 years
Brief Summary
Acute respiratory insufficiency is one of the principal causes of intensive care admission for COVID 19 positive patients. This may determine a variable mortality rate ranging from 25-30%. In these p...
Eligibility Criteria
Inclusion
- patients discharged from the intensive care unit after admission for COVID-19 respiratory insufficiency that requested non-invasive or invasive mechanical ventilation
Exclusion
- history of dementia
- history of behavior disorders
- pre-existing tracheostomy
- advanced oncologic disease
- end-stage-organ disease (dialysis, or enlisted for organ transplantation)
- no consent
Key Trial Info
Start Date :
August 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT04860687
Start Date
August 1 2021
End Date
December 31 2021
Last Update
October 7 2021
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Anesthesia and Intensive Care, Academic Hospital of Catanzaro
Catanzaro, Calabria, Italy
2
Anesthesia, Intensive Care and Pain Therapy, Academic Hospital "Federico II" of Naples
Naples, Campania, Italy
3
Anesthesia and Intensive Care, Academic Hospital of Ferrara
Ferrara, Emilia-Romagna, Italy
4
Anesthesia and Intensive Care 2, Academic Hospital of Parma
Parma, Emilia-Romagna, Italy